RxDoctor Payments Data

Delbert Johns, MD

Obstetrics & Gynecology · Fort Worth, TXNPI 1881611473

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,600 of the $13,039 with a category attached, or 73.6%. Gynesonics, Inc. accounts for 73.6% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $9,600 and has fallen 99.9% since, to $9 in 2023. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,039in general payments, 2019–2025

Across 6 payments — averaging $2173.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gynesonics, Inc.$10K
  • Aegea Medical, Inc.$3K
  • Aspira Women's Health Inc$27
  • AbbVie$16
$284,727in research payments, 2019–2025

Across 158 payments — averaging $1802.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$208K
  • Bayer$22K
  • Abbott$18K
  • Boston Scientific$18K
  • Aegea Medical, Inc.$11K
  • Gynesonics, Inc.$4K
  • plus $3K from 1 others

What the payments were for

  • Consulting fees$9,60074%
  • Speaking & faculty fees$3,39526%
  • Food & beverage$440%

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gynesonics, Inc.1$9,600
Aegea Medical, Inc.2$3,395
Aspira Women's Health Inc2$27
AbbVie1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,039 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas

Medicare billing

Part B allowed, 2024
$14,891
Medicare patients
97
Services billed
215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated12$3,332
Estradiol83$1,929
ValacyclovirValacyclovir Hcl13$497

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →